Bridging biomedicine and technology: the impact of AI & GenAI in life sciences and agribusiness

Area of Science:

• Biotechnology
• Agricultural Science
• Computational Biology

Background:

• Generative Artificial Intelligence (GenAI) represents a significant technological advancement at the intersection of biomedicine and technology.
• GenAI is increasingly utilized as a catalyst for innovation across various scientific domains.

Purpose of the Study:

• To review the multifaceted impact of GenAI in life sciences and agribusiness.
• To highlight GenAI's role in accelerating discovery, improving efficiency, and reducing costs.
• To address the ethical considerations associated with GenAI implementation.

Main Methods:

• Review of current applications of GenAI in drug discovery, protein folding, genomics, and personalized medicine.
• Analysis of GenAI's contribution to crop breeding, agricultural productivity, and synthetic biology.
• Discussion of ethical challenges including data privacy, algorithmic bias, and equitable benefit distribution.

Main Results:

• GenAI significantly expedites drug candidate identification, reducing time and costs.
• GenAI enhances understanding of diseases and facilitates personalized medicine.
• GenAI optimizes crop breeding for desired traits like disease resistance and improved yield.
• GenAI contributes to synthetic biology for bio-based manufacturing and environmental solutions.

Conclusions:

• GenAI is a transformative technology driving innovation in life sciences and agribusiness.
• Responsible implementation requires careful consideration of ethical implications, including data privacy and bias.
• Harnessing GenAI's potential promises accelerated progress in addressing critical global challenges.